Physician profile
Ronak Soni
NPI 1871978676
$3,967.60
in general payments reported to CMS, 2019-2025
26 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2021: $799 · 2022: $1,724 · 2023: $304 · 2024: $508 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $504.26 | 2021-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $449.05 | 2019-2022 | |
| Medtronic, INC. | $402.75 | 2021-2025 | Symplicity G3, Telescope, Dxterity |
| Novartis Pharmaceuticals Corporation | $387.74 | 2021-2025 | |
| Pfizer INC. | $265.67 | 2022-2025 | |
| Boston Scientific Corporation | $237.45 | 2019-2025 | Watchman, Watchman Flx |
| Amgen INC. | $226.54 | 2021-2023 | Repatha |
| Angiodynamics, INC. | $223.37 | 2022-2025 | Alphavac |
| E.R. Squibb & Sons, L.L.C. | $180.72 | 2021-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $164.60 | 2021-2024 | Farxiga |
| Inari Medical, INC. | $163.47 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astellas Pharma US INC | $99.00 | 2022 | |
| Cardiva Medical, INC. | $94.13 | 2022 | |
| Cardiovascular Systems INC. | $92.56 | 2021 | |
| Shockwave Medical, INC | $88.13 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $80.48 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.20 | 2022 | |
| Abbott Laboratories | $44.07 | 2022 | |
| Baxter Healthcare | $42.55 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $33.14 | 2024-2025 | Extended Holter, (Ck7) Extended Holter |
| Opsens INC. | $30.24 | 2022 | |
| Penumbra, INC. | $25.00 | 2022 | |
| Ge Healthcare | $24.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.38 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $21.91 | 2024 | |
| Teleflex LLC | $17.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronak Soni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.